One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...
A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...
Study looks at benefits and risks to popular weight-loss drugs; Kentucky leads nation in use of them
By Melissa Patrick and Liberty Gilbert Kentucky Health News Whether it is prescribed for diabetes or weight loss, Ozempic and ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...
Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...
Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs Red meat blamed for increased cognitive decline in ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback